Next Article in Journal
Diagnosis and Management of Catastrophic Antiphospholipid Syndrome and the Potential Impact of the 2023 ACR/EULAR Antiphospholipid Syndrome Classification Criteria
Previous Article in Journal
Performance Characteristics and Limitations of the Available Assays for the Detection and Quantitation of Monoclonal Free Light Chains and New Emerging Methodologies
 
 
Article

Article Versions Notes

Antibodies 2024, 13(1), 20; https://doi.org/10.3390/antib13010020
Action Date Notes Link
article xml file uploaded 12 March 2024 10:02 CET Original file -
article xml uploaded. 12 March 2024 10:02 CET Update -
article pdf uploaded. 12 March 2024 10:02 CET Version of Record https://www.mdpi.com/2073-4468/13/1/20/pdf-vor
article html file updated 12 March 2024 10:04 CET Original file -
article xml file uploaded 18 March 2024 01:40 CET Update -
article xml uploaded. 18 March 2024 01:40 CET Update -
article pdf uploaded. 18 March 2024 01:40 CET Updated version of record https://www.mdpi.com/2073-4468/13/1/20/pdf-vor
article html file updated 18 March 2024 01:42 CET Update -
article xml file uploaded 18 March 2024 02:29 CET Update -
article xml uploaded. 18 March 2024 02:29 CET Update -
article pdf uploaded. 18 March 2024 02:29 CET Updated version of record https://www.mdpi.com/2073-4468/13/1/20/pdf-vor
article html file updated 18 March 2024 02:31 CET Update -
article xml file uploaded 20 March 2024 11:03 CET Update -
article xml uploaded. 20 March 2024 11:03 CET Update https://www.mdpi.com/2073-4468/13/1/20/xml
article pdf uploaded. 20 March 2024 11:03 CET Updated version of record https://www.mdpi.com/2073-4468/13/1/20/pdf
article html file updated 20 March 2024 11:04 CET Update https://www.mdpi.com/2073-4468/13/1/20/html
Back to TopTop